23
Participants
Start Date
October 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
May 31, 2014
Oxycodone hydrochloride controlled-release tablets
Oxycodone hydrochloride controlled-release tablets at strengths of 10, 15, 20, 30, or 40 mg (20 mg to 240 mg daily) every 12 hours.
New York University Langone Medical Center, New York
Stony Brook University Hospital, Stony Brook
Presbyterian Blume Pediatric Hematology & Oncology Clinic, Charlotte
Jackson Memorial Hospital, Miami
Children's Hospital of Alabama, Birmingham
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
University of Kentucky, Lexington
Akron Children's Hospital, Akron
Schneider Children Medical Center of Israel, Petah Tikva
Mercy Clinic Children's Cancer and Hematology Center, St Louis
The Children's Hospital at Oklahoma University Medical Center, Oklahoma City
Children's Medical Center of Dallas, Dallas
Children's Hospital Colorado, Aurora
Bayview Research Group, LLC, Paramount
Purdue Pharma LP
INDUSTRY